Sign inJoin waitlistJoin the waitlist

Mark Kochenderfer

Physician · Oncology and Hematology Associates of Southwest Virginia Inc

Credentials: · · · · ·

History

Oncology and Hematology Associates of Southwest Virginia Inc
Present

Hematology and Medical Oncology
Wake Forest University Baptist Medical Center
2002–2005
Internal Medicine
Wake Forest University Baptist Medical Center
1999–2002
West Virginia University School of Medicine
1995–1999

Research

Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma
Journal of Clinical Oncology · 2021 · 113 citations
A randomized, phase II trial of cetuximab with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and…
Annals of Oncology · 2015 · 81 citations
Safety and Efficacy of Nivolumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study
Clinical Genitourinary Cancer · 2020 · 78 citations

IS
Ian Schnadig
3 papers
Scott Tykodi
3 papers
AS
Alexander Spira
2 papers
AC
Allen Cohn
2 papers
Ana Molina
2 papers
Antonio Jimeno
2 papers
AU
Antonio Ucar
2 papers
BS
Bradley Somer
2 papers
David McDermott
2 papers
DH
Diana Hausman
2 papers
EA
Edward Arrowsmith
2 papers
JM
Joshua McFarlane
2 papers